⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CELC News
Celcuity Inc. Common Stock
CellCentric Presents Positive Phase 2 Dose Optimization Data for Inobrodib in Multiple Myeloma at ASH Annual Meeting
newsfilecorp.com
CELC
Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
JAZZ
PRE
ABBV
AMGN
GILD
BMY
AZN
INCY
PFE
CELC
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
globenewswire.com
CELC
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference
globenewswire.com
CELC
Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
globenewswire.com
CELC
Celcuity Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
CELC
Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call
globenewswire.com
CELC
Celcuity To Present at Upcoming Stifel 2025 Healthcare Conference
globenewswire.com
CELC
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
prnewswire.com
GTBP
LPTX
IOBT
CELC
MAIA
GTBP
LPTX
IOBT
CELC
MAIA